This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...

CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

Nearly three decades since the remarkable cloning of Dolly the sheep, it has all gone quiet on the human cloning front.

The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...

A session at the AHA Scientific Sessions 2025 focused on the latest groundbreaking trails in cardiometabolic therapies.